U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
A bird nest making competition was organized, with the jury headed by U.S. ambassador John Heffern selecting the winners.
The court ruled that all provisions imposing mandatory cumulative pension system are at conflict with the country's basic law.
LCO already completed archaeological excavations in 2011 and 2012 with the restoration phase beginning this summer.
The beating of doctor Vahe Avetyan to death caused a public uproar in Armenia as hundreds of civic activists held demonstrations at the restaurant.
Partner news